跳至主要内容
临床试验/RBR-8556fzp
RBR-8556fzp已完成未知

Guided and conventional surgery for implant placement: clinical, radiographic, microbiological, imunoenzimatic and patient-centered evaluation

niversidade Paulista0 个研究点开始时间: 2022年2月17日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方

研究概览

简要总结

The objective was to compare implants installed with guided and conventional surgery, through tomographic, radiographic, immune-enzymatic, microbiological, and patient-centered evaluations.Twenty-nine 29 total edentulous patients were selected, and maxillary contralateral quadrants were randomly assigned to: Guided surgery (GS): flapless computer-guided surgery; Conventional surgery (CS): flap surgery with conventional planning. Tomography scans were performed at baseline and 10 days after the surgery to measurement deviations and radiographic evaluations were done at baseline, and after 6 and 12 months, for analysis of peri-implant bone level (PIBL). Peri-implant fluid and subgingival biofilm for the evaluation of bone markers and periodontal pathogens. The implants installed with GS showed less linear deviation at the apical point and the midpoint and less angular deviation (p<0.05). However, they presented a greater depth discrepancy in the positioning of the platform (p <0.05). Higher values of vertical PIBL were observed for GS group at baseline (p<0.05), while lower values of horizontal PIBL were observed for CS, independently of time-point evaluated (p<0,05). Bone markers, Tf and morbidity presented higher levels in CS (p<0.05). It can be concluded that the use of flapless GS for the installation of dental implants in maxillary total edentulous patients allows smaller linear and angular deviations, as well as less morbidity, than the conventional technique. However, PIBL was higher in GS and apparently the conventional technique led to a greater angiogenic and bone remodeling activity by the elevation of the levels of angiogenic, and bone markers.

研究设计

研究类型
Intervention

入排标准

年龄范围
18Y 至 0(—)

入选标准

  • Total edentulous maxillary patients; minimum bone thickness of 5.5 mm for implant placement; minimum bone height of 9 mm for placement of 6 implants.

排除标准

  • Pregnancy; lactation; antibiotic therapy in the last 6 months, long-term use of medications that could alter osseointegration, such as anti-inflammatory drugs, bisphosphates or immunosuppressive drugs; graft needs before or during surgery; history of previous regenerative procedures in the area designated for implant installation;Patients with severe complications associated with type 2 diabetes, cardiovascular disease; peripheral vascular diseases such as ulcers, gangrene or amputation; neuropathies; nephropathies.

研究者

发起方
niversidade Paulista

相似试验